Allosteric modulators of the α4β2 subtype of neuronal nicotinic acetylcholine receptors
- 15 October 2011
- journal article
- review article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 82 (8), 952-958
- https://doi.org/10.1016/j.bcp.2011.04.020
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Environmental Health Sciences
- National Institutes of Health
This publication has 72 references indexed in Scilit:
- Allosteric Modulator Desformylflustrabromine Relieves the Inhibition of α2β2 and α4β2 Nicotinic Acetylcholine Receptors by β-Amyloid1–42 PeptideJournal of Molecular Neuroscience, 2011
- Negative Allosteric Modulators That Target Human α4β2 Neuronal Nicotinic ReceptorsThe Journal of pharmacology and experimental therapeutics, 2010
- Pharmacological Characterization of the Allosteric Modulator Desformylflustrabromine and Its Interaction with α4β2 Neuronal Nicotinic Acetylcholine Receptor Orthosteric LigandsThe Journal of pharmacology and experimental therapeutics, 2010
- Gating of nicotinic ACh receptors: latest insights into ligand binding and functionThe Journal of Physiology, 2010
- Varenicline attenuates nicotine-enhanced brain-stimulation reward by activation of α4β2 nicotinic receptors in ratsNeuropharmacology, 2009
- Varenicline has antidepressant-like activity in the forced swim test and augments sertraline's effectEuropean Journal of Pharmacology, 2009
- A Novel Nicotinic Acetylcholine Receptor Subtype in Basal Forebrain Cholinergic Neurons with High Sensitivity to Amyloid PeptidesJournal of Neuroscience, 2009
- Desensitization of Nicotinic Acetylcholine Receptors as a Strategy for Drug DevelopmentThe Journal of pharmacology and experimental therapeutics, 2008
- α1β2δ, a silent GABAA receptor: recruitment by tracazolate and neurosteroidsBritish Journal of Pharmacology, 2008
- Synthesis of desformylflustrabromine and its evaluation as an α4β2 and α7 nACh receptor modulatorBioorganic & Medicinal Chemistry Letters, 2007